Interestingly, any resistance observed with the CDK2 inhibitors is believed to be due to the upregulation of CDK2 itself and selection of pre-existing polyploid cells, frequently observed in CCNE1-amplified tumor cell populations [200]. The gene discussed is CDK2; the disease is neoplasm.